A Study to Investigate the Potential Drug Interactions Between ALXN2080 and Rosuvastatin and Metformin in Healthy Adult Participants
Clinical trial NCT06160414 · COMPLETED
Trial details
- NCT number
- NCT06160414
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-12
- Primary completion
- 2024-02-05
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.